“Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial”. Link Medical Journal, vol. 4, no. 1, June 2026, pp. 1-9, https://doi.org/10.61919/061x6w21.